Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Stephen J, Streatfield"'
Autor:
Stephen, Tottey, Yoko, Shoji, R, Mark Jones, Konstantin, Musiychuk, Jessica A, Chichester, Kazutoyo, Miura, Luwen, Zhou, Shwu-Maan, Lee, Jordan, Plieskatt, Yimin, Wu, Carole A, Long, Stephen J, Streatfield, Vidadi, Yusibov
Publikováno v:
Vaccine. 41:938-944
Malaria kills around 409,000 people a year, mostly children under the age of five. Malaria transmission-blocking vaccines work to reduce malaria prevalence in a community and have the potential to be part of a multifaceted approach required to elimin
Autor:
Jerzy Karczewski, Stephen P. Krasucki, Papa Nii Asare-Okai, Carl Diehl, Andrew Friedman, Christine M. Brown, Yukari Maezato, Stephen J. Streatfield
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
We have isolated and characterized a novel antibacterial peptide, CMB001, following an extensive screening effort of bacterial species isolated from diverse environmental sources. The bacterium that produces CMB001 is characterized as a Gram (+) baci
Externí odkaz:
https://doaj.org/article/5331988770cb4ad98c3b101da797f3b5
Autor:
Prem Kumar Ganesan, Rachel J. Kulchar, Paul Kaznica, Ruben Montoya‐Lopez, Brian J. Green, Stephen J. Streatfield, Henry Daniell
Publikováno v:
Plant Biotechnology Journal. 21:244-246
Autor:
Teen-Lee Pua, Xiao Ying Chan, Hwei-San Loh, Abdul Rahman Omar, Vidadi Yusibov, Konstantin Musiychuk, Alexandra C. Hall, Megan V. Coffin, Yoko Shoji, Jessica A. Chichester, Hong Bi, Stephen J. Streatfield
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 2, Pp 306-313 (2017)
Highly pathogenic avian influenza (HPAI) H5N1 is an ongoing global health concern due to its severe sporadic outbreaks in Asia, Africa and Europe, which poses a potential pandemic threat. The development of safe and cost-effective vaccine candidates
Externí odkaz:
https://doaj.org/article/0392af64b6c54e2eb1404e47bdafbb95
Autor:
Kristopher M, Paolino, Jason A, Regules, James E, Moon, Richard C, Ruck, Jason W, Bennett, Shon A, Remich, Kristin T, Mills, Leyi, Lin, Cadeidre N, Washington, Ghariwayne A, Fornillos, Changhong Y, Lindsey, Kristan A, O'Brien, Meng, Shi, R, Mark Jones, Brian J, Green, Stephen, Tottey, Jessica A, Chichester, Stephen J, Streatfield, Vidadi, Yusibov
Publikováno v:
Vaccine. 40:1864-1871
The potential use of Bacillus anthracis as a bioterrorism weapon requires a safe and effective vaccine that can be immediately distributed for mass vaccination. Protective antigen (PA), a principal component of virulence factors edema toxin and letha
Autor:
Xu Wang, Alexei I. Prokhnevsky, Marina Skarjinskaia, Md Abdur Razzak, Stephen J. Streatfield, Jung‐Youn Lee
Publikováno v:
Plant biotechnology journal.
Molecular farming technology using transiently transformed Nicotiana plants offers an economical approach to the pharmaceutical industry to produce an array of protein targets including vaccine antigens and therapeutics. It can serve as a desirable a
Autor:
Prem Kumar, Ganesan, Rachel J, Kulchar, Paul, Kaznica, Ruben, Montoya-Lopez, Brian J, Green, Stephen J, Streatfield, Henry, Daniell
Publikováno v:
Plant biotechnology journalReferences.
Autor:
Christine M Brown, Stephen P Krasucki, Stephen J Streatfield, Jerzy Karczewski, Yukari Maezato
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:1532-1538
Objectives To evaluate the efficacy of a novel lantibiotic, CMB001, against MRSA biofilms in vitro and in an in vivo experimental model of bacterial infection. Methods Antibacterial activity of CMB001 was measured in vitro after its exposure to whole
Autor:
Tarlan Mamedov, Jessica A Chichester, R Mark Jones, Ananya Ghosh, Megan V Coffin, Kristina Herschbach, Alexey I Prokhnevsky, Stephen J Streatfield, Vidadi Yusibov
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153956 (2016)
Bacillus anthracis has long been considered a potential biological warfare agent, and therefore, there is a need for a safe, low-cost and highly efficient anthrax vaccine with demonstrated long-term stability for mass vaccination in case of an emerge
Externí odkaz:
https://doaj.org/article/8af4f0aaf9a54510b00a25fb645e57f5
Autor:
Ramon A. Ortiz, Natasha Bohorova, Anna Z. Wec, Darryl Sampey, Kartik Chandran, Nicole M. Josleyn, Stephen J. Streatfield, Jeffery W. Froude, Ognian Bohorov, Samantha E. Zak, Zachary A. Bornholdt, Russell R. Bakken, R. Mark Jones, Andrew S. Herbert, Brian J. Green, Larry Zeitlin, Ana I. Kuehne, Do Han Kim, Spencer W. Stonier, Kevin J. Whaley, Danielle E. Dorosky, Michael H. Pauly, John M. Dye, Jesus Velasco, Vidadi Yusibov, Konstantin Musiychuk
Publikováno v:
Proc Natl Acad Sci U S A
Antibody-based therapies are a promising treatment option for managing ebolavirus infections. Several Ebola virus (EBOV)-specific and, more recently, pan-ebolavirus antibody cocktails have been described. Here, we report the development and assessmen